Journal Logo

August 2004 - Volume 44 - Issue 2
pp: 137-273

(−)-(9S)-9-(3-Bromo-4-fluorophenyl)-2,3,5,6,7,9-hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide (A-278637), a Novel ATP-Sensitive Potassium Channel Opener: Hemodynamic Comparison to ZD-6169, WAY-133537, and Nifedipine in the Anesthetized Canine

Fryer, Ryan M.; Preusser, Lee C.; Calzadilla, Samuel V.; More

Journal of Cardiovascular Pharmacology. 44(2):137-147, August 2004.

The Relationship Between Flow-Mediated Brachial Artery Vasodilation and Coronary Vasomotor Responses to Bradykinin: Comparison with Those to Acetylcholine

Matsuo, Shinro; Matsumoto, Tetsuya; Takashima, Hiroyuki; More

Journal of Cardiovascular Pharmacology. 44(2):164-170, August 2004.

Rosiglitazone Improves, While Glibenclamide Worsens Blood Pressure Control in Treated Hypertensive Diabetic and Dyslipidemic Subjects via Modulation of Insulin Resistance and Sympathetic Activity

Yosefy, Chaim; Magen, Eliahu; Kiselevich, Ada; More

Journal of Cardiovascular Pharmacology. 44(2):215-222, August 2004.

In Vivo and In Vitro Characterization of the Novel Antiarrhythmic Agent SSR149744C: Electrophysiological, Anti-Adrenergic, and Anti-Angiotensin II Effects

Gautier, Patrick; Guillemare, Eric; Djandjighian, Laurent; More

Journal of Cardiovascular Pharmacology. 44(2):244-257, August 2004.